Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 3

1(20.0%)

5Total

N/A(4)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT04082611Not ApplicableCompleted

The PREVENTION Trial: Precision Recommendations to Optimize Neurocognition

Role: collaborator

NCT04968132Not ApplicableCompleted

Opioid Reduction in Orthopaedic Surgery (OREOS) - Knees

Role: collaborator

NCT04297943Not ApplicableUnknown

Orthotic Management of CMC Osteoarthritis

Role: collaborator

NCT03370237Completed

Reliability of a Diabetic Foot Ulcer Risk Stratification and Referral Algorithm

Role: collaborator

NCT01577342Not ApplicableCompleted

Determining the Effect of Antibiotic Drop Prophylaxis on the Conjunctival Flora

Role: collaborator

NCT00150696Phase 3Completed

Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury.

Role: collaborator

All 6 trials loaded